Atypical Presentation of Erythema Nodosum Following Pfizer-BioNTech COVID-19 Vaccine

BACKGROUND: Erythema nodosum (EN) is a common form of panniculitis that could be triggered by numerous conditions including infectious and non-infectious conditions. So far, few cases of EN caused by COVID-19 vaccine had been reported. CASE REPORT: We report a case of atypical presentation of EN mim...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzoabi, Nasser, Alqahtani, Jamal, Algamdi, Bader, Almutairi, Mohammed, Alratroot, Jumana, Alkhaldi, Saud, Alqahtani, Shatha, Alakloby, Omar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Medical Sciences of Bosnia and Herzegovina 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8978813/
https://www.ncbi.nlm.nih.gov/pubmed/35422564
http://dx.doi.org/10.5455/medarh.2022.76.72-74
Descripción
Sumario:BACKGROUND: Erythema nodosum (EN) is a common form of panniculitis that could be triggered by numerous conditions including infectious and non-infectious conditions. So far, few cases of EN caused by COVID-19 vaccine had been reported. CASE REPORT: We report a case of atypical presentation of EN mimicking cellulitis in a patient who received the first dose of the Pfizer-BioNTech COVID-19 vaccine. A 38-year-old healthy woman who developed painful swelling on the left leg one week after receiving the first dose of Pfizer-BioNTech COVID-19 vaccine. Skin biopsy was revealed septal panniculitis. Due to the temporal association and the absence of other identifiable causes, Pfizer-BioNTech COVID-19 vaccine-related EN would be the most likely explanation. CONCLUSION: COVID-19 vaccines could be associated with rare side effects that should be reported for a better understanding of related outcomes of COVID-19 vaccination. This case was reported to keep in mind that EN can have atypical presentation as a rare side effect of COVID-19 vaccines.

Ejemplares similares